Evidence map›Paper›PMID 26692824›Full record

ArticleThe journal of supportive oncology

Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients.

Ketty Mobed, Raymond Liu, Susan Stewart, Margaret Wrensch, Lucie McCoy, Terri Rice, Michael Prados, Susan Chang

Abstract read
PubMed Full text at PMC
In one paragraph

Article in The journal of supportive oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ketty MobedDepartment of Neurological Surgery, University of California San Francisco, San Francisco, California, and the University of California San Francisco Helen Diller Family Comprehensive Cancer Center Biostatistics Core, University of California, San Francisco, San Francisco, California.
Raymond LiuDepartment of Neurological Surgery, University of California San Francisco, San Francisco, California, and the University of California San Francisco Helen Diller Family Comprehensive Cancer Center Biostatistics Core, University of California, San Francisco, San Francisco, California.
Susan StewartDepartment of Neurological Surgery, University of California San Francisco, San Francisco, California, and the University of California San Francisco Helen Diller Family Comprehensive Cancer Center Biostatistics Core, University of California, San Francisco, San Francisco, California.
Margaret WrenschDepartment of Neurological Surgery, University of California San Francisco, San Francisco, California, and the University of California San Francisco Helen Diller Family Comprehensive Cancer Center Biostatistics Core, University of California, San Francisco, San Francisco, California.
Lucie McCoyDepartment of Neurological Surgery, University of California San Francisco, San Francisco, California, and the University of California San Francisco Helen Diller Family Comprehensive Cancer Center Biostatistics Core, University of California, San Francisco, San Francisco, California.
Terri RiceDepartment of Neurological Surgery, University of California San Francisco, San Francisco, California, and the University of California San Francisco Helen Diller Family Comprehensive Cancer Center Biostatistics Core, University of California, San Francisco, San Francisco, California.
Michael PradosDepartment of Neurological Surgery, University of California San Francisco, San Francisco, California, and the University of California San Francisco Helen Diller Family Comprehensive Cancer Center Biostatistics Core, University of California, San Francisco, San Francisco, California.
Susan ChangDepartment of Neurological Surgery, University of California San Francisco, San Francisco, California, and the University of California San Francisco Helen Diller Family Comprehensive Cancer Center Biostatistics Core, University of California, San Francisco, San Francisco, California.

Funding

Tissue CoreP50CA097257 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joseph F Costello · 2002 to 2026
$57.4M
GENETIC EPIDEMIOLOGY OF MALIGNANT GLIOMAR01CA052689 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WIENCKE, JOHN K., WRENSCH, MARGARET R. · 1991 to 2015
$20.5M
NCI NIH HHS P50 CA097257NCI NIH HHS R01 CA052689
6 · The paper itself

Abstract

Many people with cancer consider using complementary and alternative medicine (CAM). To describe the quality of life (QOL) and use of CAM therapies among adult patients with glioma, we assessed 718 patients from the Neuro-oncology Clinic at the University of California, San Francisco, between 2002 and 2006. They completed an interview on CAM use and the Functional Assessment of Cancer Treatment-Brain (FACT-Br) QOL questionnaire. Tumor grade was significantly associated with functional, brain function-related, and overall QOL. Age, gender, education, income, and marital status also were associated with various aspects of QOL. Of the 718 participants, 33% used at least one form of CAM, and 42% reported using prayer. Women and those with higher educational levels and incomes were more likely to use CAM than other patients. Tumor grade was only associated with the use of mind-body types of CAM (odds ratio [OR] = 1.87; 95% CI: 1.00-3.49;

Identifiers

PMID26692824
PMCPMC4675625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.